Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism.

Literature DB >> 26863422

Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism.

Xander G Vos¹, Erik Endert¹, A H Zwinderman¹, Jan G P Tijssen¹, Wilmar M Wiersinga¹.

Abstract

Genotyping increases the accuracy of a clinical score (based on pretreatment age, goiter size, FT4, TBII) for predicting recurrence of Graves' hyperthyroidism after a course of antithyroid drugs: a prospective study.

Entities: Disease Species

Mesh：

Substances：

Year: 2016 PMID： 26863422 DOI： 10.1210/jc.2015-3644

Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN： 0021-972X Impact factor: 5.958

Keyword Cloud
Cited

37 in total

Review 1. Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markers.

Authors: Christoph Langenstein; Diana Schork; Klaus Badenhoop; Eva Herrmann
Journal: Rev Endocr Metab Disord Date: 2016-12 Impact factor: 6.514

2. Letter to the editor: Use of radioactive iodine treatment in patients with hyperthyroidism? A case for shared decision making.

Authors: Tristan Struja; Philipp Schuetz
Journal: Eur J Nucl Med Mol Imaging Date: 2019-08-03 Impact factor: 9.236

3. The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea.

Authors: So Young Park; Bo Hyun Kim; Mijin Kim; A Ram Hong; Jun Park; Hyunju Park; Min Sun Choi; Tae Hyuk Kim; Sun Wook Kim; Ho-Cheol Kang; Jae Hoon Chung
Journal: Endocrine Date: 2021-04-15 Impact factor: 3.633

4. Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.

Authors: E Masiello; G Veronesi; D Gallo; P Premoli; E Bianconi; S Rosetti; C Cusini; J Sabatino; S Ippolito; E Piantanida; M L Tanda; L Chiovato; W M Wiersinga; L Bartalena
Journal: J Endocrinol Invest Date: 2018-06-26 Impact factor: 4.256

5. Shifting Trends and Informed Decision-Making in the Management of Graves' Disease.

Authors: Carolyn D Seib; Julie Chen; Andrei Iagaru
Journal: Thyroid Date: 2020-03 Impact factor: 6.568

6. The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.

Authors: L Bartalena; E Masiello; F Magri; G Veronesi; E Bianconi; F Zerbini; M Gaiti; E Spreafico; D Gallo; P Premoli; E Piantanida; M L Tanda; M Ferrario; P Vitti; L Chiovato
Journal: J Endocrinol Invest Date: 2016-07-27 Impact factor: 4.256

7. Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value.

Authors: Ricardo V García-Mayor; Paula Álvarez-Vázquez; Enrique Fluiters; Diana Valverde; Amalia Andrade
Journal: Endocrine Date: 2018-10-17 Impact factor: 3.633